2026-08-17T12:31:54-05:00 2025-09-30 320530003 QUIGLEY & MIRON 3580 WILSHIRE BLVD STE 1755 LOS ANGELES CA 90010 990 2025-08-01 464072112 SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK SPON 3606002170 PO BOX 55491 PORTLAND OR 97238 MAUREEN DUBREUIL MD TREASURER, VICE CHAIR 3606002170 2026-08-16 ARMEN GRIGORIAN P01582463 2136393550 2025 2025-03-06 01:10:19Z MAUREEN DUBREUIL MD PO BOX 55491 PORTLAND OR 97238 62180 0 X WWW.SPARTANGROUP.ORG X 2013 CA OUR MISSION IS TO FOSTER SPONDYLOARTHRITIS RESEARCH AND EDUCATION IN NORTH AMERICA. WE ACCOMPLISH THIS MISSION BY ENGAGING IN RESEARCH PROJECTS, SUPPORTING YOUNG RESEARCHERS, AND CONDUCTING AN ANNUAL MEETING HIGHLIGHTING IMPORTANT EDUCATION AND RESEARCH PROGRAMS. OUR VISION IS A WORLD FREE OF SPONDYLOARTHRITIS THROUGH LEADERSHIP IN RESEARCH AND EDUCATION. 11 11 0 40 0 0 1157042 55135 10618 0 71448 7045 0 0 1239108 62180 3000 310000 0 0 154690 25650 0 0 0 409766 61960 567456 397610 671652 -335430 4059121 3912478 0 0 4059121 3912478 X THE MISSION OF SPARTAN IS TO FOSTER RESEARCH AND EDUCATION IN SPONDYLOARTHRITIS IN THE UNITED STATES. SPARTAN MEMBERS ACCOMPLISH THIS MISSION BY ENGAGING IN SPECIFIC RESEARCH PROJECTS AND THROUGH AN ANNUAL MEETING, WHICH HIGHLIGHTS IMPORTANT EDUCATION AND RESEARCH PROGRAMS. 0 0 86010 SPARTAN ANNUAL MEETINGSPARTAN HOLDS AN ANNUAL MEETING TO HIGHLIGHT ADVANCES IN SPONDYLOARTHRITIS RESEARCH AND TREATMENT AND ENCOURAGE POST-DOCTORAL FELLOWS TO ENGAGE IN THE SPARTAN MISSION OF FOSTERING RESEARCH AND EDUCATION IN THE FIELD OF SPONDYLOARTHRITIS (SPA). THE RESEARCH AND EDUCATION MEETING IS ALSO AN OPPORTUNITY TO BRING TOGETHER EXPERT, DEDICATED RESEARCHERS TO IDENTIFY AND ADDRESS UNMET NEEDS IN THE FIELD OF SPA RESEARCH AND THERAPY. PRESENTERS IN THE SCIENTIFIC SESSIONS ARE THE PROMINENT INTERNATIONAL EXPERTS IN THEIR FIELDS. THE SPONDYLOARTHRITIS REVIEW COURSE IS A PRE-MEETING WORKSHOP FOR RHEUMATOLOGY FELLOWS, APPS, AND OTHER TRAINEES. WE CONDUCTED AN ULTRASOUND WORKSHOP ATTENDED BY MORE THAN 75 LEARNERS.SPARTAN RESEARCH PROJECTSBASIS (BIOMARKERS IN AXIAL SPONDYLOARTHRITIS INVESTIGATIVE STUDY) THE PRIMARY OBJECTIVE IS TO ESTABLISH A WELL-CHARACTERIZED BIOBANK FOR AXSPA AND IDENTIFY A DIAGNOSTIC BIOMARKER(S) UTILIZING A CROSS-SECTIONAL STUDY OF INDIVIDUALS WITHIN THE SPECTRUM OF AXSPA. THE BASIS STEERING COMMITTEE IS COLLABORATING WITH INDUSTRY PARTNERS AND INTENDS TO LAUNCH THE PROGRAM IN 2025. 310000 310000 SPARTAN GRANTSTHE MISSION OF SPARTAN IS TO ADVANCE RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH SPONDYLOARTHRITIS. WE FEEL STRONGLY THAT LAYING THE FOUNDATION FOR THE NEXT GENERATION OF RESEARCHERS AND LEADERS IN SPA IS AN IMPORTANT PORTAL TO ACHIEVE THIS MISSION. THE GOAL OF OUR GRANT PROGRAMS IS TO SUPPORT THE EARLY STAGES OF A FELLOW-LED RESEARCH PROJECT. WITH THE AIM OF ENCOURAGING FELLOWS TO TAKE UP RESEARCH PROJECTS UNDER MENTORS WITH EXPERTISE IN SPA, SPARTAN SUPPORTS TO 2 MENTORED FELLOWSHIP PROJECTS EACH YEAR ($10,000 PER PROJECT WITH $5,000 EACH FOR THE MENTOR AND MENTEE). SPARTAN'S EARLY CAREER INVESTIGATOR AWARD SUPPORTS EARLY CAREER INVESTIGATORS WHO ARE WORKING IN THE FIELD OF AXIAL SPONDYLOARTHRITIS AND HAS BEEN RENAMED THE EARLY CAREER INVESTIGATOR (ECI) AWARD WITH UP TO 2 NEW GRANTS SUPPORTED ($25,000 PER PROJECT PER YEAR FOR TWO YEARS) ANNUALLY. TRAVEL AWARDS GO TO THE TOP 3 ABSTRACTS TO SUPPORT TRAVEL TO INDUSTRY MEETINGS (3 AWARDS @ $1,000 EACH). 396010 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 1 1 0 0 0 CA X X THE ORGANIZATION 3606002170 PO BOX 55491 PORTLAND OR 97238 MATTHEW STOLL PHD MD CHAIR 10.00 X X 0 0 0 JOERG ERMANN MD IMMEDIATE PAST CHAIR 3.00 X X 0 0 0 IGNACIO GARCIA-VALLARDES MD DIRECTOR 2.00 X 0 0 0 SIBA RAYCHAUDHURI MD DIRECTOR 2.00 X 0 0 0 MAUREEN DUBREUIL MD TREASURER, VICE-CHAIR 2.00 X X 0 0 0 NIGIL HAROON PHD MD VICE-CHAIR 3.00 X X 0 0 0 JEAN LIEW MD MSC DIRECTOR 3.00 X 0 0 0 MARINA MAGREY MD SECRETARY 2.00 X X 0 0 0 JOHN REVEILLE MD DIRECTOR 2.00 X 0 0 0 MOHAMAD BITTAR MD DIRECTOR 3.00 X 0 0 0 AKIHIRO NAKAMURA MD PHD DIRECTOR 2.00 X 0 0 0 LISA SPIEGEL EXECUTIVE DIRECTOR 30.00 X 0 0 0 0 0 0 55135 55135 7045 7045 62180 0 0 7045 310000 310000 25650 25650 1600 1600 60360 60360 397610 396010 1600 0 668105 96520 1303097 1013615 2087919 2802343 4059121 3912478 0 0 X 4059121 3912478 4059121 3912478 4059121 3912478 X -335430 52751 136036 X X 0 0 0 X 1196324 999000 630000 1157042 55135 4037501 1196324 999000 630000 1157042 55135 4037501 2940109 1097392 113 36362 71448 7045 114968 111 7255 7366 4159835 81368 0.26380 0.26090 X 1. SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK (SPARTAN) HAS PUBLIC SUPPORT OF 29% , OVER TWO AND A HALF TIMES THE MINIMUM AMOUNT REQUIRED TO BE A PUBLIC CHARITY. 2. SPARTAN IS A PROFESSIONAL SOCIETY THAT RECEIVES SUPPORT FROM MULTIPLE PHARMACEUTICAL COMPANIES. EACH OF THESE PHARMACEUTICAL COMPANIES ARE PUBLICLY OWNED AND THEREFORE REPRESENT MILLIONS OF INDIVIDUAL SHAREHOLDERS. ADDITIONALLY, SPARTAN'S ACTIVITIES BENEFIT APPROXIMATELY 7 MILLION INDIVIDUALS, WHICH IS VERY SUBSTANTIAL PERCENTAGE OF THE POPULATION OF THE UNITED STATES. MUCH OF SPARTAN'S FOCUS CENTERS ON RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH CHRONIC BACK PAIN, AS WELL AS THE TREATMENT OF THOSE IN WHOM THE BACK PAIN IS FOUND TO HAVE AN INFLAMMATORY CAUSE (SPONDYLOARTHRITIS). APPROXIMATELY 8% OF ADULTS HAVE CHRONIC BACK PAIN, AND ABOUT 1% OF THE ADULT POPULATION HAS SPONDYLARTHRITIS. EVEN WITH THE MOST CONSERVATIVE ESTIMATES, MILLIONS OF PEOPLE IN THE UNITED STATES, AND EVEN MORE WORLDWIDE, ARE IMPACTED BY SPARTAN'S ACTIVITIES.3. SPARTAN HAS A GOVERNING BODY MADE UP OF 11 LEADERS IN THE FIELD, WHO EDUCATE THE PUBLIC AND ARE SCIENTISTS AND EXPERTS IN PROVIDING CARE TO PATIENTS WITH BACK PAIN. SPECIFICALLY, WE HAVE A HIGHLY DIVERSE GOVERNING BODY AS EVIDENCED BY (A) GEOGRAPHIC DIVERSITY, WITH BOARD MEMBERS FROM ALL OVER THE UNITED STATES (ALABAMA, CALIFORNIA, MASSACHUSETTS, OHIO, TEXAS, AND UTAH) AS WELL AS CANADA AND MEXICO; AND (B) LEADERS IN BOTH PEDIATRIC (DR. STOLL) AS WELL AS ADULT (NAKEMURA, GARCIA-VALLARDARES, DUBREUIL, ERMANN, HAROON, LIEW, MAGREY, BITTAR, REVEILLE, RAYCHAUDHURI).4. MEDICAL RESEARCH WHICH IS SPONSORED BY SPARTAN IS MADE AVAILABLE TO THE GENERAL PUBLIC AND IS PUBLISHED IN SCHOLARLY JOURNALS. THE RECIPIENTS OF SPARTAN GRANTS ARE REQUIRED TO PUBLISH THEIR HIGH IMPACT WORK IN PEER-REVIEWED MEDICAL JOURNALS. ADDITIONALLY, AS A LEADER IN THE COMMUNITY, SPARTAN DEVELOPED AND PUBLISHED IN 2016 AND UPDATED IN 2019 RECOMMENDATIONS THAT GUIDE TREATMENT OF PATIENTS WITH SPONDYLOARTHRITIS ACROSS THE WORLD. SPARTAN HAS MADE THESE GUIDELINES AVAILABLE WITHOUT CHARGE TO ALL INTERESTED PARTIES, INCLUDING PATIENTS AS WELL AS PROVIDERS AND THIRD-PARTY PAYERS. 5. SPARTAN'S PROGRAMS ARE SPONSORED AND RUN BY MEMBERS OF THE PUBLIC WITH SPECIAL KNOWLEDGE AND EXPERTISE. SPECIFICALLY, THE PHARMACEUTICAL DONORS HAVE SELECTED SPARTAN BASED UPON MUTUAL KNOWLEDGE OF AND INTEREST IN SPONDYLOARTHRITIS. SPARTAN MEMBERS ARE SELECTED ON THE BASIS OF RECOGNIZED EXPERTISE IN TREATMENT, EDUCATION, OR RESEARCH WITHIN THE FIELD OF SPONDYLOARTHRITIS.6. SPARTAN MAINTAINS A COMPREHENSIVE PROGRAM TO ACCOMPLISH ITS CHARITABLE WORK: FOSTERING RESEARCH AND EDUCATION IN SPONDYLOARTHRITIS IN THE UNITED STATES. SPECIFICALLY, SINCE ITS INCEPTION IN 2013, SPARTAN HAS MAINTAINED A PROGRAM TO FUND PILOT AND SEED RESEARCH GRANTS TO SCIENTISTS STUDYING VARIOUS ASPECTS OF SPONDYLOARTHRITIS. ADDING TO THE IMPACT OF THESE GRANTS IS THAT THEY ARE TARGETED TO JUNIOR RESEARCHERS, ENSURING A CONTINUED PIPELINE OF PHYSICIAN SCIENTISTS WHO WILL CARE FOR AND STUDY SPONDYLOARTHRITIS WELL INTO THE FUTURE. ALL GRANT APPLICATIONS ARE REVIEWED BY AN IMPARTIAL, UNCONFLICTED GROUP OF EXPERTS, AND THE DOLLAR VALUE OF THE AWARDS IS COMMENSURATE WITH SIMILAR GRANTS OFFERED BY NON-PROFIT ORGANIZATIONS, INCLUDING ACADEMIC FACILITIES. THE FINAL VOTE TO APPROVE THE GRANTS IS MADE BY THE SPARTAN BOARD OF DIRECTORS DURING ITS REGULARLY SCHEDULED MEETINGS, OF WHICH MINUTES ARE MAINTAINED. ADDITIONALLY, SPARTAN HAS RECURRING EDUCATIONAL PROGRAMS AIMED AT RHEUMATOLOGY TRAINEES, PROVIDERS CARING FOR PATIENTS WITH SPONDYLOARTHRITIS, AND PROVIDERS OUTSIDE RHEUMATOLOGY WHO MAY ENCOUNTER THESE PATIENTS PRIOR TO DIAGNOSIS. THESE ACTIVITIES BENEFIT THE PROFESSIONAL PERFORMANCE OF HEALTH CARE PROVIDERS TAKING CARE OF PATIENTS WITH SPONDYLOARTHRITIS AND OTHER INFLAMMATORY RHEUMATIC DISEASES AND, INDIRECTLY, MILLIONS OF PATIENTS.7. SPARTAN'S REQUESTS FOR MEMBERSHIP ARE DESIGNED TO ENROLL A SUBSTANTIAL NUMBER OF MEMBERS OF THE COMMUNITY. SPECIFICALLY, SPARTAN ENCOURAGES TRAINEES TO JOIN SPARTAN. THERE ARE LEVELS OF MEMBERSHIP THAT INCLUDE PHYSICIANS WITH VARYING LEVELS OF EXPERIENCE AND EXPERTISE IN THE FIELD; INCLUDING RHEUMATOLOGISTS, GASTROENTEROLOGISTS, RADIOLOGISTS AND OPHTHALMOLOGISTS. PART II, SHORT YEAR EXPLANATION: THE ORGANIZATION'S CURRENT FILING REPRESENTS A SHORT-YEAR SPANNING FROM 8/1/2025 THROUGH 9/30/2025. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 1111 FRANKLIN ST 12TH FLOOR OAKLAND CA 94607 943067788 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 1111 FRANKLIN ST 12TH FLOOR OAKLAND CA 94607 943067788 50000 0 SPONDYLOARTHRITIS RESEARCH GRANT THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 7000 FANNIN SUITE 1706 HOUSTON TX 77030 741761309 100000 0 SPONDYLOARTHRITIS RESEARCH GRANT UNIVERSITY OF WASHINGTON 1410 NE CAMPUS PARKWAY SEATTLE WA 98195 916001537 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT THE UNIVERSITY OF ALABAMA 1720 2ND AVE S BIRMINGHAM AL BIRMINGHAM AL 35294 636005396 50000 0 SPONDYLOARTHRITIS RESEARCH GRANT 6 FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWED THE FORM 990 PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12 EACH DIRECTOR, PRINCIPAL OFFICER, AND COMMITTEE MEMBER ANNUALLY SIGNS A STATEMENT WHICH: 1) AFFIRMS THAT THE PERSON HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY, HAS READ AND UNDERSTOOD THE POLICY, AND HAS AGREED TO COMPLY WITH THE POLICY; AND 2) DISCLOSES THAT PERSON'S INTERESTS THAT COULD REASONABLY GIVE RISE TO CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: CORRECTION OF PRIOR YEAR MISSTATED ASSET BALANCES 136,036. FORM 990, PART XII, LINE 2C: THE ORGANIZATION'S AUDIT COMMITTEE HAS RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF THE INDEPENDENT AUDITOR, SUBJECT TO THE APPROVAL OF THE BOARD OR DIRECTORS.